community download

"Vigilance in Pharmacovigilance: Human Factors and Attention"

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

 

At the 2014 Drug Safety Congress Europe event, Alan Hochberg, F Hoffmann La-Roche AG, gave the presentation "Vigilance in Pharmacovigilance: Human Factors and Attention." 

Alan Hochberg exoplores:

  • What is happening?

  • What does this mean?

  • Nature of errors made in case and literature review which may be due to lack of vigilance

  • Can’t we just hire more people and divide up the work?

  • Vigilance decrement

  • Person approach vs. system approach to human error

  • What are the implications for pharmacovigilance?

  • Candidates for optimization of the data quantity/quality tradeoff:

  • Should we try a structured methodology for error analysis?

  • Conclusions